IL2 and multidrug-resistant tuberculosis: We hypothesized that IL-2 play a crucial role in modulating Th17, Treg cells responses in patients with MDR-TB, thereby maintaining the balance between protection and pathology, which defines the outcome of MDR-TB infections.